Medtronic Reaffirms $43B Covidien Bid Despite Opposition
Medical device maker Medtronic Inc. said Tuesday it is "fully committed" to proceeding with its $42.9 billion acquisition of rival Covidien PLC even as the controversial plan, which would shift company...To view the full article, register now.
Already a subscriber? Click here to view full article